Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Genmab to Discontinue Development of Enapotamab Vedotin (2020-11-24)
> Genmab will not advance the development of enapotamab vedotin > Data from expansion cohorts did not meet stringent criteria for proof-of-concept > Genmab to prioritize development of other innovative product candidates Genmab A/S (Nasdaq: GMAB) announc...
Evotec & Rappta Therapeutics: Cancer Drug RnD Partnership (2020-11-24)
> EVOTEC TO SUPPORT RAPPTA IN DEVELOPING SMALL MOLECULES THAT REACTIVATE PP2A, A KEY TUMOR SUPPRESSOR > THE COLLABORATION LEVERAGES EVOTEC'S ONCOLOGY EXPERTISE AND INTEGRATED DRUG DISCOVERY AND DEVELOPMENT PLATFORM Evotec SE (Frankfurt Stock Exchange: EVT, ...
ISD Immunotech Partners with Biogen, Investment from Novo (2020-11-23)
> Developing STING Antagonist for Treatment of Severe Lupus > New Investment by Novo Holdings ISD Immunotech (ISD), which is developing targeted therapies for severe autoimmune diseases, today announces it has entered into a strategic research collaboration...
SynOx Therapeutics’ €37m Series A Led by HealthCap & Medicxi (2020-11-19)
> Financing to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumours SynOx Therapeutics Ltd ("SynOx"), a clinical stage biopharmaceutical company, announces today the closing of a €37 million Series A financing co-led by Hea...
BRAND NEW – the [LSE] Newsletter Is Out! (2020-11-12)
You can read the latest version of the [LSE] Newsletter online at https://www.life-sciences-europe.com/newsletter/lse-newsletter-021011-aaaz.html...
Synendos Therapeutics Raises CHF20m Series A Financing (2020-11-12)
> Breakthrough approach to developing safe and effective therapies for unmet needs in neuropsychiatric disorders > Financing will allow Synendos Therapeutics to complete pre-clinical development and progress lead candidate through proof of concept clinical study...
BRAND NEW – the [LSG] Newsletter Is Out! (2020-11-10)
You can read the latest version of the [LSG] Newsletter online at http://www.life-sciences-germany.com/newsletter/lsg-newsletter-021011-abba.html...
Novo Invests in $57m Series A of Stargazer Pharmaceuticals (2020-11-09)
Stargazer Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel treatment options for rare eye diseases, announced it has completed a Series A financing totalling USD 57 million from leading investors Novo Holdings, venBio Partners,...
BRAND NEW – the [LSUS] Newsletter Is Out! (2020-11-08)
You can read the latest version of the [LSUS] Newsletter online at https://www.life-sciences-europe.com/newsletter/lsus-newsletter-021011-asex.html This issue features: Novo Nordisk – Emisphere Technologies – PerkinElmer – Horizon Discovery – Sanofi – Kiadis ...
PledPharma Appoints Henrik Krook VP Commercial Operations (2020-11-06)
PledPharma AB (STO: PLED) today announced that Henrik Krook takes on the position as Vice President Commercial Operations at PledPharma. The appointment is complementing PledPharma’s acquisition of Rare Thyroid Therapeutics (RTT), creating a new focused orphan drug...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

» Start here with the latest News!

Picture ConsulTech GmbH RnD Credit Germany 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top